TRIMAS CORPORATION

TRS

CIK 0000842633 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$155M
↑+3.8% +$6Mvs FY2024 (Q4)
Operating Income
$17M
↑+316.3% +$13Mvs FY2024 (Q4)
Net Income
$12M
Gross Profit
$33M
↑+46.5% +$10Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
53/100
  • Profitability
    0ROIC 3.7% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.52 (above 1.5 = solid)
  • Leverage
    66D/E 0.67 (under 0.5 = conservative)
  • Efficiency
    20Asset Turnover 0.46x (1.0+ = capital-efficient)
  • Growth
    29Revenue YoY +3.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 10.0% · trend +5.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project TRS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 37.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$56.50
Total enterprise IV
$2.30B
Diluted shares
0.04B
Terminal PV
$1.79B (78% of total)
Year-5 FCF
$211M
YearProjected FCFDiscounted PV
+1$86M$79M
+2$108M$89M
+3$135M$101M
+4$169M$115M
+5$211M$131M
Terminal$2.88B$1.79B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$48M
investment in PP&E
Dividends paid (TTM)
$7M
cash returned to holders
Stock buybacks (TTM)
$103M
share count reduction
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.49B
everything owned
Total liabilities
$779M
everything owed
Stockholders' equity
$706M
shareholder claim
Net debt
$443M
LT debt minus cash

Recent performance · 63 quarters

Revenue↑+3.8% +$6M
$155M
Net Income↑+1348.6% +$76M
$82M
Free Cash Flow↑+204.3% +$25M
$37M
Operating Margin↑+4.8pts
10.0%

Drill down